WHO-GMP certified manufacturer of enteric coated and sustained release pellets, DC granules, APIs and intermediates for pharmaceutical formulators in India and 58+ countries.
Enteric Coated Pellets • Sustained Release Pellets • MUPS Pellets • DC Granules • APIs • Intermediates
Analgesic and anti-inflammatory pellets engineered for cardiovascular support regimens. Uniform pellet size and controlled moisture deliver reliable dissolution in low-dose aspirin therapies.
WHO-GMP compliant anti-platelet pellets supporting secondary prevention of atherothrombotic events. Built for consistent layering to maintain bioavailability in fixed-dose combinations.
Dual anti-platelet pellets that balance particle size between both actives, streamlining fixed-dose regimens for post-PCI maintenance and high-risk cardiovascular patients.
Enteric-coated pellets formulated for serotonin-norepinephrine reuptake inhibitor therapies addressing depression, neuropathic pain, and generalized anxiety disorders.
Dual delayed-release pellets targeting extended acid suppression, ideal for once-daily GERD control with staged gastric release.
Multiparticulate pellets for flexible delayed-release formulation development in proton pump inhibitor programs.
Enteric-coated esomeprazole pellets with tight moisture control to maintain proton pump inhibition for GERD and erosive esophagitis regimens.
Magnesium-trihydrate based pellets built for high acid resistance and rapid dissolution convergence, supporting chronic GERD therapy.
Bilayered pellets combining acid suppression with prokinetic support, engineered to minimise segregation in capsule fills.
Beyond catalogue products, Rraynex offers pellet development from pilot to commercial scale, pellet coating, contract manufacturing and technology transfer. The team can share DMF access, stability data and custom formulation options for your project.